Renaissance Technologies
CLBT icon

Renaissance Technologies’s Cellebrite CLBT Stock Holding History

Renaissance Technologies’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4M Sell
2,150,239
-710,400
-25% -$9.39M 0.04% 513
2026
Q1 		$39.4M Buy
2,860,639
+365,700
+15% +$5.51M 0.06% 396
2025
Q4 		$45M Sell
2,494,939
-407,166
-14% -$7.31M 0.07% 320
2025
Q3 		$53.8M Buy
2,902,105
+215,766
+8% +$3.39M 0.07% 329
2025
Q2 		$43M Buy
2,686,339
+76,000
+3% +$1.35M 0.06% 395
2025
Q1 		$50.7M Buy
2,610,339
+979,900
+60% +$20.6M 0.08% 316
2024
Q4 		$35.9M Buy
1,630,439
+115,939
+8% +$2.23M 0.05% 433
2024
Q3 		$25.5M Buy
1,514,500
+330,800
+28% +$4.91M 0.04% 558
2024
Q2 		$14.1M Buy
1,183,700
+214,600
+22% +$2.4M 0.02% 750
2024
Q1 		$10.7M Sell
969,100
-82,056
-8% -$838K 0.02% 954
2023
Q4 		$9.1M Buy
1,051,156
+727,756
+225% +$5.66M 0.01% 995
2023
Q3 		$2.47M Buy
323,400
+126,100
+64% +$946K ﹤0.01% 1732
2023
Q2 		$1.42M Buy
197,300
+120,700
+158% +$704K ﹤0.01% 2221
2023
Q1 		$466K Buy
76,600
+63,300
+476% +$343K ﹤0.01% 2920
2022
Q4 		$58K Buy
+13,300
New +$59.4K ﹤0.01% 3769

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Renaissance Technologies's CLBT Position: Q2 2026 in Review

Renaissance Technologies reduced its Cellebrite (CLBT) stake by 25% in Q2 2026, selling an estimated $9.39M and leaving 2,150,239 shares worth $31.4M. The position accounts for 0.04% of the portfolio, ranked #513.

Renaissance Technologies first reported a position in CLBT in Q4 2022 and has held it in 15 quarters since. The position peaked at $53.8M in Q3 2025. 134 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Renaissance Technologies held 2,150,239 shares of Cellebrite worth $31.4M as of Q2 2026.
  • Renaissance Technologies sold 710,400 Cellebrite shares in Q2 2026, an estimated $9.39M.
  • Cellebrite made up 0.04% of Renaissance Technologies's portfolio in Q2 2026, its #513 holding.
  • Renaissance Technologies first reported a position in Cellebrite in Q4 2022 and has held it in 15 quarters since.
  • Renaissance Technologies's Cellebrite position peaked at $53.8M in Q3 2025.
  • 134 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.